Italia markets close in 2 hours 6 minutes

JNJ Jan 2026 200.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,44000,0000 (0,00%)
In data: 11:44AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,4400
Aperto1,4400
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio200,00
Scadenza2026-01-16
Min-Max giorno1,4400 - 1,4400
Contratto - Min-MaxN/D
Volume3
Open Interest2,15k
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA